Help Us Protect Access to Sexual and Reproductive Health Care Today!
Apr 16
Since the Supreme Court overturned Roe v. Wade, medical providers in states where abortion is banned or severely restricted have struggled to understand how state laws apply to them and their patients. This resource from the Abortion Defense Network aims to provide clarification, where possible, of what conduct is permitted in the states where the…
Apr 16
By Joi C. Spaulding MD, MS Opill, a daily progestin-only birth control pill (POP), was first approved for over-the-counter (OTC) use by the United States Food and Drug Administration (FDA) on July 13, 2023. As of March 2024, the pill is now available to people of all ages to purchase at retailers online and in…
Apr 16
This poster compares birth control choices based on efficacy, cost, side effects, and other patient-focused factors.
Mar 26
Written by Rebecca Wang, JD, Senior Legal Support Counsel and Lauren Paulk, JD, Senior Research Counsel Mandatory reporting is not an evidence-based practice. Neither is punishing providers for a failure to report. Still, healthcare provider reports to Child Protective Services of infants have increased substantially over the last decade.¹ This is despite only two states…
Mar 20
CPT, ICD-10, out-patient procedure, medication administration, and other codes to use for documenting and billing medication abortion services.
Mar 19
By Natalie Cheung-Jones, DO During perimenopause, some people have inconsistent ovulation and irregular menses. Despite these changes, pregnancy occurs for 30% of pregnancy-capable people ages 40-44, decreasing to 10% by ages 45-50.¹ Though menstrual cycles may be unpredictable, studies indicate that ovulation occurs in 87% of cycles up to five years before menopause and 22%…
Feb 27
Written by Sadia A study by the Guttmacher Institute shows that over half of all abortions are done via medication abortion (MAB), using misoprostol only or mifepristone with misoprostol.¹ Patients who have a MAB often wonder about the need for a follow-up appointment. Follow-up appointments are used to determine if the MAB was successful. Health…
Feb 20
By Lakshmi Sundaresan, MD Polycystic Ovary Syndrome (PCOS) is a common endocrinological phenomenon, often manifesting with symptoms of irregular periods, coarse facial/terminal hair, and glucose intolerance.¹ Conventionally, treatments for PCOS are tailored to the manifestations of hyperandrogenism, insulin resistance, and menstrual irregularities that patients experience. In 2023, the International PCOS practice guidelines were updated to…
Feb 14
This factsheet explains basic information about ectopic pregnancy, including the symptoms, tests a patient might need, treatment, and future risks. Spanish: Updated June/junio 2024 Reading Grade Level (Flesch-Kincaid Grade Level): 5.5
Feb 06
This is a progestin re-injection calendar based on three month/15 week dosing intervals with the flexibility of dosing between weeks 11 – 15.